First patient enrolled in phase II study of ImaginAb's CD8+ T-cell Immuno-PET imaging agent Jan. 22, 2019
Phase III RESOLVE trial of ibrutinib in metastatic pancreatic cancer misses primary endpoint Jan. 21, 2019
RSS